ID   PDE4B_HUMAN             Reviewed;         736 AA.
AC   Q07343; A5YW33; O15443; Q13945; Q5TEK4; Q5TEK5; Q5TEK6;
DT   01-FEB-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1995, sequence version 1.
DT   22-JUL-2015, entry version 153.
DE   RecName: Full=cAMP-specific 3',5'-cyclic phosphodiesterase 4B;
DE            EC=3.1.4.53;
DE   AltName: Full=DPDE4;
DE   AltName: Full=PDE32;
GN   Name=PDE4B; Synonyms=DPDE4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM PDE4B2).
RX   PubMed=8392015; DOI=10.1016/0378-1119(93)90274-7;
RA   Obernolte R., Bhakta S., Alvarez R., Bach C., Mulkins M., Jarnagin K.,
RA   Shelton E.R.;
RT   "The cDNA of a human lymphocyte cyclic-AMP phosphodiesterase (PDE IV)
RT   reveals a multigene family.";
RL   Gene 129:239-247(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS PDE4B1 AND PDE4B2).
RC   TISSUE=Brain;
RX   PubMed=8413254;
RA   Bolger G., Michaeli T., Martins T., St John T., Steiner B.,
RA   Rodgers L., Riggs M., Wigler M., Ferguson K.;
RT   "A family of human phosphodiesterases homologous to the dunce learning
RT   and memory gene product of Drosophila melanogaster are potential
RT   targets for antidepressant drugs.";
RL   Mol. Cell. Biol. 13:6558-6571(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM PDE4B3).
RX   PubMed=9371714;
RA   Huston E., Lumb S., Russell A., Catterall C., Ross A.H., Steele M.R.,
RA   Bolger G.B., Perry M.J., Owens R.J., Houslay M.D.;
RT   "Molecular cloning and transient expression in COS7 cells of a novel
RT   human PDE4B cAMP-specific phosphodiesterase, HSPDE4B3.";
RL   Biochem. J. 328:549-558(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM PDE4B2).
RC   TISSUE=Brain;
RX   PubMed=8384210;
RA   McLaughlin M.M., Cieslinski L.B., Burman M., Torphy T.J., Livi G.P.;
RT   "A low-Km, rolipram-sensitive, cAMP-specific phosphodiesterase from
RT   human brain. Cloning and expression of cDNA, biochemical
RT   characterization of recombinant protein, and tissue distribution of
RT   mRNA.";
RL   J. Biol. Chem. 268:6470-6476(1993).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM PDE4B5).
RX   PubMed=17519386; DOI=10.1124/jpet.107.122218;
RA   Cheung Y.F., Kan Z., Garrett-Engele P., Gall I., Murdoch H.,
RA   Baillie G.S., Camargo L.M., Johnson J.M., Houslay M.D., Castle J.C.;
RT   "PDE4B5, a novel, super-short, brain-specific cAMP phosphodiesterase-4
RT   variant whose isoform-specifying N-terminal region is identical to
RT   that of cAMP phosphodiesterase-4D6 (PDE4D6).";
RL   J. Pharmacol. Exp. Ther. 322:600-609(2007).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS PDE4B1; PDE4B3 AND
RP   PDE4B5).
RC   TISSUE=Hippocampus, and Thalamus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM PDE4B1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (1.77 ANGSTROMS) OF 324-700 IN COMPLEX WITH
RP   METAL IONS, FUNCTION, AND COFACTOR.
RX   PubMed=10846163; DOI=10.1126/science.288.5472.1822;
RA   Xu R.X., Hassell A.M., Vanderwall D., Lambert M.H., Holmes W.D.,
RA   Luther M.A., Rocque W.J., Milburn M.V., Zhao Y., Ke H., Nolte R.T.;
RT   "Atomic structure of PDE4: insights into phosphodiesterase mechanism
RT   and specificity.";
RL   Science 288:1822-1825(2000).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 324-700 IN COMPLEX WITH AMP;
RP   METAL IONS AND THE INHIBITOR ROLIPRAM, FUNCTION, AND COFACTOR.
RX   PubMed=15003452; DOI=10.1016/j.jmb.2004.01.040;
RA   Xu R.X., Rocque W.J., Lambert M.H., Vanderwall D.E., Luther M.A.,
RA   Nolte R.T.;
RT   "Crystal structures of the catalytic domain of phosphodiesterase 4B
RT   complexed with AMP, 8-Br-AMP, and rolipram.";
RL   J. Mol. Biol. 337:355-365(2004).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.15 ANGSTROMS) OF 324-700 IN COMPLEX WITH AMP
RP   AND METAL IONS.
RX   PubMed=15260978; DOI=10.1016/j.molcel.2004.07.005;
RA   Zhang K.Y.J., Card G.L., Suzuki Y., Artis D.R., Fong D., Gillette S.,
RA   Hsieh D., Neiman J., West B.L., Zhang C., Milburn M.V., Kim S.-H.,
RA   Schlessinger J., Bollag G.;
RT   "A glutamine switch mechanism for nucleotide selectivity by
RT   phosphodiesterases.";
RL   Mol. Cell 15:279-286(2004).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (1.92 ANGSTROMS) OF 324-700 IN COMPLEX WITH
RP   METAL IONS AND INHIBITORS.
RX   PubMed=15576036; DOI=10.1016/j.str.2004.10.004;
RA   Card G.L., England B.P., Suzuki Y., Fong D., Powell B., Lee B.,
RA   Luu C., Tabrizizad M., Gillette S., Ibrahim P.N., Artis D.R.,
RA   Bollag G., Milburn M.V., Kim S.-H., Schlessinger J., Zhang K.Y.J.;
RT   "Structural basis for the activity of drugs that inhibit
RT   phosphodiesterases.";
RL   Structure 12:2233-2247(2004).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (2.40 ANGSTROMS) OF 324-700 IN COMPLEX WITH
RP   METAL IONS AND INHIBITORS.
RX   PubMed=15685167; DOI=10.1038/nbt1059;
RA   Card G.L., Blasdel L., England B.P., Zhang C., Suzuki Y., Gillette S.,
RA   Fong D., Ibrahim P.N., Artis D.R., Bollag G., Milburn M.V., Kim S.-H.,
RA   Schlessinger J., Zhang K.Y.J.;
RT   "A family of phosphodiesterase inhibitors discovered by
RT   cocrystallography and scaffold-based drug design.";
RL   Nat. Biotechnol. 23:201-207(2005).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (1.95 ANGSTROMS) OF 324-659 IN COMPLEX WITH
RP   METAL IONS AND THE INHIBITOR NVP.
RX   PubMed=17727341; DOI=10.1042/BJ20070970;
RA   Wang H., Peng M.-S., Chen Y., Geng J., Robinson H., Houslay M.D.,
RA   Cai J., Ke H.;
RT   "Structures of the four subfamilies of phosphodiesterase-4 provide
RT   insight into the selectivity of their inhibitors.";
RL   Biochem. J. 408:193-201(2007).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) OF 324-675 IN COMPLEX WITH
RP   METAL IONS AND INHIBITOR.
RX   PubMed=18539455; DOI=10.1016/j.bmcl.2008.05.052;
RA   Hamblin J.N., Angell T.D.R., Ballantine S.P., Cook C.M.,
RA   Cooper A.W.J., Dawson J., Delves C.J., Jones P.S., Lindvall M.,
RA   Lucas F.S., Mitchell C.J., Neu M.Y., Ranshaw L.E., Solanke Y.E.,
RA   Somers D.O., Wiseman J.O.;
RT   "Pyrazolopyridines as a novel structural class of potent and selective
RT   PDE4 inhibitors.";
RL   Bioorg. Med. Chem. Lett. 18:4237-4241(2008).
CC   -!- FUNCTION: Hydrolyzes the second messenger cAMP, which is a key
CC       regulator of many important physiological processes. May be
CC       involved in mediating central nervous system effects of
CC       therapeutic agents ranging from antidepressants to antiasthmatic
CC       and anti-inflammatory agents. {ECO:0000269|PubMed:10846163,
CC       ECO:0000269|PubMed:15003452}.
CC   -!- CATALYTIC ACTIVITY: Adenosine 3',5'-cyclic phosphate + H(2)O =
CC       adenosine 5'-phosphate.
CC   -!- COFACTOR:
CC       Name=a divalent metal cation; Xref=ChEBI:CHEBI:60240;
CC         Evidence={ECO:0000269|PubMed:10846163,
CC         ECO:0000269|PubMed:15003452};
CC       Note=Binds 2 divalent metal cations per subunit. Site 1 may
CC       preferentially bind zinc ions, while site 2 has a preference for
CC       magnesium and/or manganese ions. {ECO:0000269|PubMed:10846163,
CC       ECO:0000269|PubMed:15003452};
CC   -!- ENZYME REGULATION: Inhibited by rolipram.
CC   -!- PATHWAY: Purine metabolism; 3',5'-cyclic AMP degradation; AMP from
CC       3',5'-cyclic AMP: step 1/1.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=PDE4B1;
CC         IsoId=Q07343-1; Sequence=Displayed;
CC       Name=PDE4B2;
CC         IsoId=Q07343-2; Sequence=VSP_004572;
CC       Name=PDE4B3;
CC         IsoId=Q07343-3; Sequence=VSP_004571;
CC       Name=PDE4B5;
CC         IsoId=Q07343-4; Sequence=VSP_047723, VSP_047724;
CC         Note=Brain-specific isoform.;
CC   -!- TISSUE SPECIFICITY: Expressed in brain, heart, lung and skeletal
CC       muscle.
CC   -!- SIMILARITY: Belongs to the cyclic nucleotide phosphodiesterase
CC       family. PDE4 subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA35643.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L12686; AAA35643.1; ALT_INIT; mRNA.
DR   EMBL; L20966; AAA03589.1; -; mRNA.
DR   EMBL; L20971; AAA03593.1; -; mRNA.
DR   EMBL; U85048; AAB96381.1; -; mRNA.
DR   EMBL; M97515; AAA36426.1; -; mRNA.
DR   EMBL; EF595686; ABQ85407.1; -; mRNA.
DR   EMBL; AK289969; BAF82658.1; -; mRNA.
DR   EMBL; AK290006; BAF82695.1; -; mRNA.
DR   EMBL; AK290206; BAF82895.1; -; mRNA.
DR   EMBL; AL592285; CAH70626.1; -; Genomic_DNA.
DR   EMBL; AL109926; CAH70626.1; JOINED; Genomic_DNA.
DR   EMBL; AL357273; CAH70626.1; JOINED; Genomic_DNA.
DR   EMBL; AL359701; CAH70626.1; JOINED; Genomic_DNA.
DR   EMBL; AL592285; CAH70628.1; -; Genomic_DNA.
DR   EMBL; AL109926; CAH70628.1; JOINED; Genomic_DNA.
DR   EMBL; AL357273; CAH70628.1; JOINED; Genomic_DNA.
DR   EMBL; AL359701; CAH70628.1; JOINED; Genomic_DNA.
DR   EMBL; AL357273; CAH73002.1; -; Genomic_DNA.
DR   EMBL; AL109926; CAH73002.1; JOINED; Genomic_DNA.
DR   EMBL; AL359701; CAH73002.1; JOINED; Genomic_DNA.
DR   EMBL; AL592285; CAH73002.1; JOINED; Genomic_DNA.
DR   EMBL; AL357273; CAH73004.1; -; Genomic_DNA.
DR   EMBL; AL109926; CAH73004.1; JOINED; Genomic_DNA.
DR   EMBL; AL359701; CAH73004.1; JOINED; Genomic_DNA.
DR   EMBL; AL592285; CAH73004.1; JOINED; Genomic_DNA.
DR   EMBL; AL109926; CAI21749.1; -; Genomic_DNA.
DR   EMBL; AL357273; CAI21749.1; JOINED; Genomic_DNA.
DR   EMBL; AL359701; CAI21749.1; JOINED; Genomic_DNA.
DR   EMBL; AL592285; CAI21749.1; JOINED; Genomic_DNA.
DR   EMBL; AL109926; CAI21750.1; -; Genomic_DNA.
DR   EMBL; AL359701; CAI21750.1; JOINED; Genomic_DNA.
DR   EMBL; AL109926; CAI21751.1; -; Genomic_DNA.
DR   EMBL; AL357273; CAI21751.1; JOINED; Genomic_DNA.
DR   EMBL; AL359701; CAI21751.1; JOINED; Genomic_DNA.
DR   EMBL; AL592285; CAI21751.1; JOINED; Genomic_DNA.
DR   EMBL; AL359701; CAI23099.1; -; Genomic_DNA.
DR   EMBL; AL109926; CAI23099.1; JOINED; Genomic_DNA.
DR   EMBL; AL357273; CAI23099.1; JOINED; Genomic_DNA.
DR   EMBL; AL592285; CAI23099.1; JOINED; Genomic_DNA.
DR   EMBL; AL359701; CAI23100.1; -; Genomic_DNA.
DR   EMBL; AL109926; CAI23100.1; JOINED; Genomic_DNA.
DR   EMBL; AL359701; CAI23101.1; -; Genomic_DNA.
DR   EMBL; AL109926; CAI23101.1; JOINED; Genomic_DNA.
DR   EMBL; AL357273; CAI23101.1; JOINED; Genomic_DNA.
DR   EMBL; AL592285; CAI23101.1; JOINED; Genomic_DNA.
DR   EMBL; AL513493; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL590783; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL591487; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471059; EAX06524.1; -; Genomic_DNA.
DR   EMBL; BC101480; AAI01481.1; -; mRNA.
DR   EMBL; BC105040; AAI05041.1; -; mRNA.
DR   CCDS; CCDS30742.1; -. [Q07343-3]
DR   CCDS; CCDS30743.1; -. [Q07343-2]
DR   CCDS; CCDS632.1; -. [Q07343-1]
DR   CCDS; CCDS72802.1; -. [Q07343-4]
DR   PIR; I61354; I61354.
DR   RefSeq; NP_001032416.1; NM_001037339.2. [Q07343-2]
DR   RefSeq; NP_001032417.1; NM_001037340.2. [Q07343-3]
DR   RefSeq; NP_001032418.1; NM_001037341.1. [Q07343-1]
DR   RefSeq; NP_001284369.1; NM_001297440.1.
DR   RefSeq; NP_001284370.1; NM_001297441.1.
DR   RefSeq; NP_001284371.1; NM_001297442.1. [Q07343-4]
DR   RefSeq; NP_002591.2; NM_002600.3. [Q07343-1]
DR   UniGene; Hs.198072; -.
DR   PDB; 1F0J; X-ray; 1.77 A; A/B=324-700.
DR   PDB; 1JP1; Model; -; A=324-700.
DR   PDB; 1JP2; Model; -; A=324-700.
DR   PDB; 1RO6; X-ray; 2.00 A; A/B=324-700.
DR   PDB; 1RO9; X-ray; 2.13 A; A/B=324-700.
DR   PDB; 1ROR; X-ray; 2.00 A; A/B=324-700.
DR   PDB; 1TB5; X-ray; 2.15 A; A/B=324-700.
DR   PDB; 1XLX; X-ray; 2.19 A; A/B=324-700.
DR   PDB; 1XLZ; X-ray; 2.06 A; A/B=324-700.
DR   PDB; 1XM4; X-ray; 2.31 A; A/B=324-700.
DR   PDB; 1XM6; X-ray; 1.92 A; A/B=324-700.
DR   PDB; 1XMU; X-ray; 2.30 A; A/B=324-700.
DR   PDB; 1XMY; X-ray; 2.40 A; A/B=324-700.
DR   PDB; 1XN0; X-ray; 2.31 A; A/B=324-700.
DR   PDB; 1XOS; X-ray; 2.28 A; A=324-700.
DR   PDB; 1XOT; X-ray; 2.34 A; A/B=324-700.
DR   PDB; 1Y2H; X-ray; 2.40 A; A/B=324-700.
DR   PDB; 1Y2J; X-ray; 2.55 A; A/B=324-700.
DR   PDB; 2CHM; X-ray; 1.60 A; A=450-475.
DR   PDB; 2QYL; X-ray; 1.95 A; A=324-659.
DR   PDB; 3D3P; X-ray; 1.75 A; A=324-675.
DR   PDB; 3FRG; X-ray; 1.70 A; A=324-675.
DR   PDB; 3G45; X-ray; 2.63 A; A/B=241-289, A/B=305-659.
DR   PDB; 3GWT; X-ray; 1.75 A; A=324-675.
DR   PDB; 3HC8; X-ray; 1.79 A; A=451-474.
DR   PDB; 3HDZ; X-ray; 1.80 A; A=451-474.
DR   PDB; 3HMV; X-ray; 2.23 A; A/B=324-700.
DR   PDB; 3KKT; X-ray; 2.48 A; A/B=324-700.
DR   PDB; 3LY2; X-ray; 2.60 A; A/B/C/D/E/F/G/H=324-659.
DR   PDB; 3O0J; X-ray; 1.95 A; A=334-656.
DR   PDB; 3O56; X-ray; 2.42 A; A=324-675.
DR   PDB; 3O57; X-ray; 2.00 A; A=324-675.
DR   PDB; 3W5E; X-ray; 2.30 A; A/B=324-700.
DR   PDB; 3WD9; X-ray; 2.50 A; A/B=324-700.
DR   PDB; 4KP6; X-ray; 1.50 A; A=324-659.
DR   PDB; 4MYQ; X-ray; 1.90 A; A=324-691.
DR   PDB; 4NW7; X-ray; 2.15 A; A=324-691.
DR   PDB; 4WZI; X-ray; 2.58 A; A/B=122-736.
DR   PDB; 4X0F; X-ray; 3.22 A; A/B=122-736.
DR   PDBsum; 1F0J; -.
DR   PDBsum; 1JP1; -.
DR   PDBsum; 1JP2; -.
DR   PDBsum; 1RO6; -.
DR   PDBsum; 1RO9; -.
DR   PDBsum; 1ROR; -.
DR   PDBsum; 1TB5; -.
DR   PDBsum; 1XLX; -.
DR   PDBsum; 1XLZ; -.
DR   PDBsum; 1XM4; -.
DR   PDBsum; 1XM6; -.
DR   PDBsum; 1XMU; -.
DR   PDBsum; 1XMY; -.
DR   PDBsum; 1XN0; -.
DR   PDBsum; 1XOS; -.
DR   PDBsum; 1XOT; -.
DR   PDBsum; 1Y2H; -.
DR   PDBsum; 1Y2J; -.
DR   PDBsum; 2CHM; -.
DR   PDBsum; 2QYL; -.
DR   PDBsum; 3D3P; -.
DR   PDBsum; 3FRG; -.
DR   PDBsum; 3G45; -.
DR   PDBsum; 3GWT; -.
DR   PDBsum; 3HC8; -.
DR   PDBsum; 3HDZ; -.
DR   PDBsum; 3HMV; -.
DR   PDBsum; 3KKT; -.
DR   PDBsum; 3LY2; -.
DR   PDBsum; 3O0J; -.
DR   PDBsum; 3O56; -.
DR   PDBsum; 3O57; -.
DR   PDBsum; 3W5E; -.
DR   PDBsum; 3WD9; -.
DR   PDBsum; 4KP6; -.
DR   PDBsum; 4MYQ; -.
DR   PDBsum; 4NW7; -.
DR   PDBsum; 4WZI; -.
DR   PDBsum; 4X0F; -.
DR   ProteinModelPortal; Q07343; -.
DR   SMR; Q07343; 335-681.
DR   BioGrid; 111168; 9.
DR   IntAct; Q07343; 3.
DR   STRING; 9606.ENSP00000332116; -.
DR   BindingDB; Q07343; -.
DR   ChEMBL; CHEMBL2111340; -.
DR   DrugBank; DB00131; Adenosine monophosphate.
DR   DrugBank; DB01427; Amrinone.
DR   DrugBank; DB00201; Caffeine.
DR   DrugBank; DB00651; Dyphylline.
DR   DrugBank; DB00824; Enprofylline.
DR   DrugBank; DB05266; Ibudilast.
DR   DrugBank; DB01088; Iloprost.
DR   DrugBank; DB00920; Ketotifen.
DR   DrugBank; DB01113; Papaverine.
DR   DrugBank; DB00806; Pentoxifylline.
DR   DrugBank; DB01656; Roflumilast.
DR   DrugBank; DB01412; Theobromine.
DR   DrugBank; DB00277; Theophylline.
DR   GuidetoPHARMACOLOGY; 1301; -.
DR   PhosphoSite; Q07343; -.
DR   BioMuta; PDE4B; -.
DR   DMDM; 729163; -.
DR   MaxQB; Q07343; -.
DR   PaxDb; Q07343; -.
DR   PRIDE; Q07343; -.
DR   Ensembl; ENST00000329654; ENSP00000332116; ENSG00000184588.
DR   Ensembl; ENST00000341517; ENSP00000342637; ENSG00000184588.
DR   Ensembl; ENST00000371045; ENSP00000360084; ENSG00000184588. [Q07343-2]
DR   Ensembl; ENST00000423207; ENSP00000392947; ENSG00000184588. [Q07343-3]
DR   Ensembl; ENST00000480109; ENSP00000432592; ENSG00000184588. [Q07343-4]
DR   GeneID; 5142; -.
DR   KEGG; hsa:5142; -.
DR   UCSC; uc001dcn.3; human. [Q07343-1]
DR   UCSC; uc001dcp.3; human. [Q07343-3]
DR   UCSC; uc001dcq.3; human.
DR   UCSC; uc009was.3; human.
DR   CTD; 5142; -.
DR   GeneCards; GC01P066339; -.
DR   HGNC; HGNC:8781; PDE4B.
DR   HPA; HPA003005; -.
DR   MIM; 600127; gene.
DR   neXtProt; NX_Q07343; -.
DR   PharmGKB; PA33129; -.
DR   eggNOG; NOG122287; -.
DR   GeneTree; ENSGT00760000118889; -.
DR   HOGENOM; HOG000236297; -.
DR   HOVERGEN; HBG108239; -.
DR   KO; K13293; -.
DR   OMA; TCFDVEN; -.
DR   OrthoDB; EOG7HQNBC; -.
DR   PhylomeDB; Q07343; -.
DR   TreeFam; TF314638; -.
DR   BRENDA; 3.1.4.53; 2681.
DR   Reactome; REACT_15334; DARPP-32 events.
DR   Reactome; REACT_19327; G alpha (s) signalling events.
DR   UniPathway; UPA00762; UER00747.
DR   ChiTaRS; PDE4B; human.
DR   EvolutionaryTrace; Q07343; -.
DR   GeneWiki; PDE4B; -.
DR   GenomeRNAi; 5142; -.
DR   NextBio; 19828; -.
DR   PRO; PR:Q07343; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; Q07343; -.
DR   CleanEx; HS_PDE4B; -.
DR   ExpressionAtlas; Q07343; baseline and differential.
DR   Genevisible; Q07343; HS.
DR   GO; GO:0071944; C:cell periphery; IEA:Ensembl.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0016020; C:membrane; IEA:Ensembl.
DR   GO; GO:0030018; C:Z disc; ISS:BHF-UCL.
DR   GO; GO:0004115; F:3',5'-cyclic-AMP phosphodiesterase activity; IDA:BHF-UCL.
DR   GO; GO:0030552; F:cAMP binding; IGI:BHF-UCL.
DR   GO; GO:0044325; F:ion channel binding; ISS:BHF-UCL.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0006198; P:cAMP catabolic process; IDA:BHF-UCL.
DR   GO; GO:0035690; P:cellular response to drug; ISS:BHF-UCL.
DR   GO; GO:0071872; P:cellular response to epinephrine stimulus; ISS:BHF-UCL.
DR   GO; GO:0071222; P:cellular response to lipopolysaccharide; ISS:BHF-UCL.
DR   GO; GO:0050900; P:leukocyte migration; ISS:BHF-UCL.
DR   GO; GO:1901898; P:negative regulation of relaxation of cardiac muscle; ISS:BHF-UCL.
DR   GO; GO:0030593; P:neutrophil chemotaxis; ISS:BHF-UCL.
DR   GO; GO:0001780; P:neutrophil homeostasis; ISS:BHF-UCL.
DR   GO; GO:0032729; P:positive regulation of interferon-gamma production; IMP:BHF-UCL.
DR   GO; GO:0032743; P:positive regulation of interleukin-2 production; IMP:BHF-UCL.
DR   GO; GO:0086004; P:regulation of cardiac muscle cell contraction; ISS:BHF-UCL.
DR   GO; GO:1901841; P:regulation of high voltage-gated calcium channel activity; ISS:BHF-UCL.
DR   GO; GO:0050852; P:T cell receptor signaling pathway; IMP:BHF-UCL.
DR   Gene3D; 1.10.1300.10; -; 1.
DR   InterPro; IPR003607; HD/PDEase_dom.
DR   InterPro; IPR023088; PDEase.
DR   InterPro; IPR002073; PDEase_catalytic_dom.
DR   InterPro; IPR023174; PDEase_CS.
DR   Pfam; PF00233; PDEase_I; 1.
DR   PRINTS; PR00387; PDIESTERASE1.
DR   SMART; SM00471; HDc; 1.
DR   PROSITE; PS00126; PDEASE_I; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; cAMP; Complete proteome;
KW   Hydrolase; Metal-binding; Polymorphism; Reference proteome.
FT   CHAIN         1    736       cAMP-specific 3',5'-cyclic
FT                                phosphodiesterase 4B.
FT                                /FTId=PRO_0000198809.
FT   NP_BIND     406    410       cAMP.
FT   ACT_SITE    406    406       Proton donor.
FT   METAL       410    410       Divalent metal cation 1.
FT   METAL       446    446       Divalent metal cation 1.
FT   METAL       447    447       Divalent metal cation 1.
FT   METAL       447    447       Divalent metal cation 2.
FT   METAL       564    564       Divalent metal cation 1.
FT   BINDING     447    447       cAMP.
FT   BINDING     564    564       cAMP.
FT   BINDING     615    615       cAMP.
FT   SITE        567    567       Binds AMP, but not cAMP. {ECO:0000250}.
FT   VAR_SEQ       1    211       MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWR
FT                                GRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTL
FT                                PSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHAT
FT                                FPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDL
FT                                IVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPV
FT                                SRVNPQ -> MKEHGGTFSSTGISGGSGDSAMDSLQPLQPN
FT                                YMPVCLFA (in isoform PDE4B2).
FT                                {ECO:0000303|PubMed:8384210,
FT                                ECO:0000303|PubMed:8392015,
FT                                ECO:0000303|PubMed:8413254}.
FT                                /FTId=VSP_004572.
FT   VAR_SEQ       1     93       MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWR
FT                                GRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTL
FT                                PSIAITTVSQE -> MTAKDSSKELTASEPEVCIKTFKEQM
FT                                HLELELPRLPGNRPTSPKISPRSSPRNSPCFFRKLLVNKSI
FT                                RQRRRFTVAHT (in isoform PDE4B3).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:9371714}.
FT                                /FTId=VSP_004571.
FT   VAR_SEQ       1     15       MKKSRSVMTVMADDN -> MPEANYLLSVSWGYI (in
FT                                isoform PDE4B5).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:17519386}.
FT                                /FTId=VSP_047723.
FT   VAR_SEQ      16    248       Missing (in isoform PDE4B5).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:17519386}.
FT                                /FTId=VSP_047724.
FT   VARIANT     703    703       S -> C (in dbSNP:rs2227297).
FT                                /FTId=VAR_034373.
FT   HELIX       168    183       {ECO:0000244|PDB:4WZI}.
FT   HELIX       217    235       {ECO:0000244|PDB:4WZI}.
FT   HELIX       239    264       {ECO:0000244|PDB:4WZI}.
FT   HELIX       266    279       {ECO:0000244|PDB:4WZI}.
FT   HELIX       324    327       {ECO:0000244|PDB:3G45}.
FT   STRAND      328    330       {ECO:0000244|PDB:3FRG}.
FT   TURN        332    334       {ECO:0000244|PDB:1XMU}.
FT   HELIX       335    342       {ECO:0000244|PDB:4KP6}.
FT   TURN        343    346       {ECO:0000244|PDB:4KP6}.
FT   HELIX       352    358       {ECO:0000244|PDB:4KP6}.
FT   TURN        359    361       {ECO:0000244|PDB:1RO6}.
FT   HELIX       363    374       {ECO:0000244|PDB:4KP6}.
FT   HELIX       377    380       {ECO:0000244|PDB:4KP6}.
FT   HELIX       385    397       {ECO:0000244|PDB:4KP6}.
FT   STRAND      403    407       {ECO:0000244|PDB:4KP6}.
FT   HELIX       408    422       {ECO:0000244|PDB:4KP6}.
FT   HELIX       425    427       {ECO:0000244|PDB:4KP6}.
FT   TURN        428    430       {ECO:0000244|PDB:4KP6}.
FT   HELIX       433    445       {ECO:0000244|PDB:4KP6}.
FT   TURN        446    449       {ECO:0000244|PDB:4KP6}.
FT   HELIX       455    460       {ECO:0000244|PDB:4KP6}.
FT   HELIX       464    468       {ECO:0000244|PDB:4KP6}.
FT   TURN        469    471       {ECO:0000244|PDB:4KP6}.
FT   HELIX       474    486       {ECO:0000244|PDB:4KP6}.
FT   HELIX       490    492       {ECO:0000244|PDB:3FRG}.
FT   TURN        494    497       {ECO:0000244|PDB:4KP6}.
FT   HELIX       500    515       {ECO:0000244|PDB:4KP6}.
FT   HELIX       519    521       {ECO:0000244|PDB:4KP6}.
FT   HELIX       522    534       {ECO:0000244|PDB:4KP6}.
FT   STRAND      540    542       {ECO:0000244|PDB:2QYL}.
FT   HELIX       549    564       {ECO:0000244|PDB:4KP6}.
FT   HELIX       567    569       {ECO:0000244|PDB:4KP6}.
FT   HELIX       572    595       {ECO:0000244|PDB:4KP6}.
FT   HELIX       602    604       {ECO:0000244|PDB:3FRG}.
FT   TURN        606    608       {ECO:0000244|PDB:4KP6}.
FT   HELIX       611    621       {ECO:0000244|PDB:4KP6}.
FT   HELIX       623    633       {ECO:0000244|PDB:4KP6}.
FT   TURN        634    638       {ECO:0000244|PDB:4KP6}.
FT   HELIX       639    654       {ECO:0000244|PDB:4KP6}.
FT   STRAND      656    658       {ECO:0000244|PDB:1RO6}.
FT   STRAND      659    662       {ECO:0000244|PDB:3KKT}.
FT   HELIX       664    666       {ECO:0000244|PDB:3KKT}.
FT   HELIX       671    677       {ECO:0000244|PDB:1F0J}.
SQ   SEQUENCE   736 AA;  83343 MW;  208FCE9CD40EF5EB CRC64;
     MKKSRSVMTV MADDNVKDYF ECSLSKSYSS SSNTLGIDLW RGRRCCSGNL QLPPLSQRQS
     ERARTPEGDG ISRPTTLPLT TLPSIAITTV SQECFDVENG PSPGRSPLDP QASSSAGLVL
     HATFPGHSQR RESFLYRSDS DYDLSPKAMS RNSSLPSEQH GDDLIVTPFA QVLASLRSVR
     NNFTILTNLH GTSNKRSPAA SQPPVSRVNP QEESYQKLAM ETLEELDWCL DQLETIQTYR
     SVSEMASNKF KRMLNRELTH LSEMSRSGNQ VSEYISNTFL DKQNDVEIPS PTQKDREKKK
     KQQLMTQISG VKKLMHSSSL NNTSISRFGV NTENEDHLAK ELEDLNKWGL NIFNVAGYSH
     NRPLTCIMYA IFQERDLLKT FRISSDTFIT YMMTLEDHYH SDVAYHNSLH AADVAQSTHV
     LLSTPALDAV FTDLEILAAI FAAAIHDVDH PGVSNQFLIN TNSELALMYN DESVLENHHL
     AVGFKLLQEE HCDIFMNLTK KQRQTLRKMV IDMVLATDMS KHMSLLADLK TMVETKKVTS
     SGVLLLDNYT DRIQVLRNMV HCADLSNPTK SLELYRQWTD RIMEEFFQQG DKERERGMEI
     SPMCDKHTAS VEKSQVGFID YIVHPLWETW ADLVQPDAQD ILDTLEDNRN WYQSMIPQSP
     SPPLDEQNRD CQGLMEKFQF ELTLDEEDSE GPEKEGEGHS YFSSTKTLCV IDPENRDSLG
     ETDIDIATED KSPVDT
//
